3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
3
Gynecologic
2
Dermatologic
2
CNS
2
Head & Neck
1
Conditions
Melanoma
15
Carcinoma, Basal Cell
6
Skin Neoplasms
5
Recurrence
2
Neoplasm Metastasis
2
Uveal Melanoma
1
Neoplasms
1
Lentigo Maligna Melanoma (Head or Neck)
1
Eyelid Squamous Cell Carcinoma
1
Eye Neoplasms
1
Eye Diseases
1
Death
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Advanced Head and Neck Squamous Cell Carcinoma
1
Interventions
Peripheral Blood Stem Cell Transplantation
23
fludarabine phosphate
20
Cyclophosphamide
18
Mycophenolic Acid
16
Whole-Body Irradiation
15
Cyclosporine
15
Busulfan
12
Tacrolimus
11
Methotrexate
10
Antilymphocyte Serum
9
Radiotherapy
8
Melphalan
8
Etoposide
8
pembrolizumab
7
Methylprednisolone
6
Filgrastim
6
Sirolimus
4
Prednisone
4
Nivolumab
4
sargramostim
3
Vincristine
3
Transplantation
3
Therapeutics
3
Polymerase Chain Reaction
3
Cord Blood Stem Cell Transplantation
3
Amplified Fragment Length Polymorphism Analysis
3
mogamulizumab
2
merphos
2
bempegaldesleukin
2
Voriconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recurrence
×
Surgical Procedures, Operative
×
Dermatologic
×
Clear all
NCT06363591
2025-03-05
WoW
Vastra Gotaland Region
Phase NA
Recruiting
2,486 enrolled
NCT00975520
2024-11-27
RTN2
Melanoma and Skin Cancer Trials Limited
Phase NA
Completed
50 enrolled